KPW
ONC

Kore Private Wealth’s BeOne Medicines Ltd ONC Stock Holding History

Kore Private Wealth’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13
Closed -$2K – 1122
2020
Q2 		$2K Buy
+13
New +$2.12K ﹤0.01% 1059

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Kore Private Wealth's ONC Position: Q3 2020 in Review

Kore Private Wealth sold out of BeOne Medicines Ltd (ONC) in Q3 2020, closing a stake of 13 shares — an estimated $2K sold.

Kore Private Wealth first reported a position in ONC in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 243 funds tracked by Wall St. Rank hold ONC as of Q3 2020.

  • Kore Private Wealth reported no remaining BeOne Medicines Ltd position as of Q3 2020 after selling out during the quarter.
  • Kore Private Wealth sold 13 BeOne Medicines Ltd shares in Q3 2020, an estimated $2K.
  • Kore Private Wealth first reported a position in BeOne Medicines Ltd in Q2 2020 and held it in 1 quarter.
  • Kore Private Wealth's BeOne Medicines Ltd position peaked at $2K in Q2 2020.
  • 243 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.